-
Product Insights
NewOphthalmic Imaging Equipment Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Ophthalmic Imaging equipment is used to create images to aid in the diagnosis and treatment of eye diseases. GlobalData's Medical Devices sector report, “Ophthalmic Imaging Equipment Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Ophthalmic Imaging Equipment pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Ophthalmic Imaging Equipment report provides...
-
Sector Analysis
NewNew Drug Approvals and Their Contract Manufacture – 2024 Edition
This report is the 14th edition of our long-running analysis of the CMO industry, using the FDA's NDA approvals as the primary indicator of performance. New Drug Approvals and Their Contract Manufacture (formerly called "CMO Scorecard") is critical for benchmarking the performance of the contract manufacturing organization (CMO) industry and the relative performance of major CMOs. This year's edition includes a discussion of how inflation and increasing global conflict has impacted pharma manufacturers.
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – TT-16 in Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TT-16 in Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TT-16 in...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Dovitinib Lactate in Metastatic Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Dovitinib Lactate in Metastatic Ovarian Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dovitinib Lactate in Metastatic Ovarian Cancer Drug Details: Dovitinib...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Apalutamide in Salivary Gland Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Apalutamide in Salivary Gland Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Apalutamide in Salivary Gland Cancer Drug Details: Apalutamide (Erleada, Erlyand,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pembrolizumab in Vaginal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pembrolizumab in Vaginal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pembrolizumab in Vaginal Cancer Drug Details: Pembrolizumab (Keytruda) is an antineoplastic...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cabometyx in Endometrial Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cabometyx in Endometrial Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cabometyx in Endometrial Cancer Drug Details: Cabozantinib s-malate (Cabometyx, Aptimetyx) is a...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cabometyx in Neuroblastoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cabometyx in Neuroblastoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cabometyx in Neuroblastoma Drug Details: Cabozantinib s-malate (Cabometyx, Aptimetyx) is a s-malate salt...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cabometyx in Hepatobiliary System Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cabometyx in Hepatobiliary System Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cabometyx in Hepatobiliary System Tumor Drug Details: Cabozantinib s-malate (Cabometyx,...